The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients

OBJECTIVE: Patients with breast cancer (BC) who are obese or overweight at the time of diagnosis have a low survival rate and a high death rate. We aimed to investigate if having a higher body mass index (BMI) at diagnosis raised the risk of local recurrence (LR) and distant metastasis. PATIENTS AND...

Full description

Bibliographic Details
Main Authors: R. Mohamed, M. Melek, S. Eid, A. Morsy
Format: Article
Language:English
Published: Verduci Editore 2023-05-01
Series:World Cancer Research Journal
Subjects:
Online Access:https://www.wcrj.net/wp-content/uploads/sites/5/2023/05/e2553.pdf
_version_ 1827915575356030976
author R. Mohamed
M. Melek
S. Eid
A. Morsy
author_facet R. Mohamed
M. Melek
S. Eid
A. Morsy
author_sort R. Mohamed
collection DOAJ
description OBJECTIVE: Patients with breast cancer (BC) who are obese or overweight at the time of diagnosis have a low survival rate and a high death rate. We aimed to investigate if having a higher body mass index (BMI) at diagnosis raised the risk of local recurrence (LR) and distant metastasis. PATIENTS AND METHODS: Patients were divided into three categories based on their BMI. The patient's BMI was determined by dividing his weight in kilograms by his height in square meters (kg/m2). The WHO defines normal weight as 18.5 ≤ BMI < 25 kg/m2, overweight as 25 ≤ BMI < 30 kg/m2, and obesity as BMI ≥ 30 kg/m2. RESULTS: The mean BMI was 30.27±6.06 kg/m2. Out of 250 patients, 60 (24.0%), 73 (29.2%) and 117 (46.8%) patients had normal, overweight and obese BMI respectively. No significant difference between BMI and estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) was found, but there was an association between tumor (T) stage and lymph vascular invasion (LVI) (p<0.05). Obese patients had poorer disease-free survival (DFS) and overall survival (OS) than normal and overweight categories (35.38 ±1.72 vs. 42.38 ± 2.79 and 37.82 ± 2.27 months) (39.65±1.65 vs.45.70 ± 2.53 and 44.31 ± 2.04 months) (p<0.001). LR occurs more prevalent in over-weight and obese patients than normal (p<0.03) but there is no significant difference for distant metastasis. CONCLUSIONS: There is a strong negative association between increased BMI and BC prognosis and patient survival; controlling of this phenomenon may improve the response to treatment and survival, therefore health awareness programs should be implemented.
first_indexed 2024-03-13T03:01:49Z
format Article
id doaj.art-9e86058808cb460ebc443f3c87fa61a5
institution Directory Open Access Journal
issn 2372-3416
language English
last_indexed 2024-03-13T03:01:49Z
publishDate 2023-05-01
publisher Verduci Editore
record_format Article
series World Cancer Research Journal
spelling doaj.art-9e86058808cb460ebc443f3c87fa61a52023-06-27T12:16:31ZengVerduci EditoreWorld Cancer Research Journal2372-34162023-05-011010.32113/wcrj_20235_25532553The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patientsR. Mohamed0M. Melek1S. Eid2A. Morsy3Clinical Oncology Department, Faculty of Medicine, Assiut University Hospitals, Assuit, EgyptEl-Mabarah Health Insurance Hospital, Assuit, EgyptClinical Oncology Department, Faculty of Medicine, Assiut University Hospitals, Assuit, EgyptClinical Oncology Department, Faculty of Medicine, Assiut University Hospitals, Assuit, EgyptOBJECTIVE: Patients with breast cancer (BC) who are obese or overweight at the time of diagnosis have a low survival rate and a high death rate. We aimed to investigate if having a higher body mass index (BMI) at diagnosis raised the risk of local recurrence (LR) and distant metastasis. PATIENTS AND METHODS: Patients were divided into three categories based on their BMI. The patient's BMI was determined by dividing his weight in kilograms by his height in square meters (kg/m2). The WHO defines normal weight as 18.5 ≤ BMI < 25 kg/m2, overweight as 25 ≤ BMI < 30 kg/m2, and obesity as BMI ≥ 30 kg/m2. RESULTS: The mean BMI was 30.27±6.06 kg/m2. Out of 250 patients, 60 (24.0%), 73 (29.2%) and 117 (46.8%) patients had normal, overweight and obese BMI respectively. No significant difference between BMI and estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2) was found, but there was an association between tumor (T) stage and lymph vascular invasion (LVI) (p<0.05). Obese patients had poorer disease-free survival (DFS) and overall survival (OS) than normal and overweight categories (35.38 ±1.72 vs. 42.38 ± 2.79 and 37.82 ± 2.27 months) (39.65±1.65 vs.45.70 ± 2.53 and 44.31 ± 2.04 months) (p<0.001). LR occurs more prevalent in over-weight and obese patients than normal (p<0.03) but there is no significant difference for distant metastasis. CONCLUSIONS: There is a strong negative association between increased BMI and BC prognosis and patient survival; controlling of this phenomenon may improve the response to treatment and survival, therefore health awareness programs should be implemented.https://www.wcrj.net/wp-content/uploads/sites/5/2023/05/e2553.pdfbmibreast cancerdistant metastasislocal recurrence
spellingShingle R. Mohamed
M. Melek
S. Eid
A. Morsy
The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients
World Cancer Research Journal
bmi
breast cancer
distant metastasis
local recurrence
title The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients
title_full The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients
title_fullStr The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients
title_full_unstemmed The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients
title_short The correlation between increasing Body Mass Index and the incidence of local recurrence and distant metastasis in breast cancer patients
title_sort correlation between increasing body mass index and the incidence of local recurrence and distant metastasis in breast cancer patients
topic bmi
breast cancer
distant metastasis
local recurrence
url https://www.wcrj.net/wp-content/uploads/sites/5/2023/05/e2553.pdf
work_keys_str_mv AT rmohamed thecorrelationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT mmelek thecorrelationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT seid thecorrelationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT amorsy thecorrelationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT rmohamed correlationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT mmelek correlationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT seid correlationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients
AT amorsy correlationbetweenincreasingbodymassindexandtheincidenceoflocalrecurrenceanddistantmetastasisinbreastcancerpatients